“The experts associated with Harrington are extremely valuable because of their market awareness and knowledge of the commercial aspects required for successfully advancing a new molecule to the clinic. As an academic scientist, that part of drug development is totally unknown to me."
TRAVIS DUNCKLEY, PhD
Assistant Research Professor
ASU-Banner Neurodegenerative Disease Research Center
Arizona State University
2016 ADDF-Harrington Scholar
The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute provide funding and drug development support of research efforts that aim to treat or prevent Alzheimer’s disease, related dementias and cognitive-decline associated with aging. Each year up to two ADDF-Harrington Scholars are chosen. The award includes:
Join our emailing list to become a part of our community and receive periodic communications about grant funding opportunities, as well as news and updates.
Late submissions will not be accepted for any reason, other than issues with the Harrington Discovery Institute’s submission system. Proposals received after the deadline will not be reviewed.
The ADDF-Harrington Scholar award selection committee seeks breakthrough discoveries that demonstrate innovation, creativity and potential for clinical impact, including:
